Extra-virgin olive oil (EVOO) has been hypothesized to have chemopreventive effects on breast cancer, unlike high corn oil (HCO) diets that stimulate it. We have investigated mechanisms of these differential modulatory actions on experimental mammary cancer. In 7,12-dimethylbenz(a)anthracene adenocarcinomas of rats fed a high EVOO, HCO and control diets (n 5 20 for each group), we have analyzed the expression and activity of ErbB receptors, p21Ras and its extracellular signal-regulated kinase (ERK) 1/2, Akt and RalA/B effectors by immunoblotting analyses. We explored the Ha-ras1 mutation status by Southern blot, mismatch amplification mutation assay and sequencing, and the 3-hydroxy-3-methylglutaryl-coenzyme A reductase and squalene synthase messenger RNA expression by real-time polymerase chain reaction. We analyzed the tumor mitotic index, proliferating cell nuclear antigen (PCNA) levels, and apoptosis through Caspase-3 analysis and terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick end labeling assays. Finally, we measured the 8-oxo-2#-deoxyguanosine levels. Nonparametrical statistics were used. The EVOO diet decreased Ras activation, downregulated the Ras/phosphatidyl inositol 3-kinase/Akt pathway and upregulated the Raf/Erk pathway, compared with the control. In contrast, the HCO diet did not modify Ras activity but rather enhanced the Raf/Erk pathway. The EVOO diet decreased the cleaved ErbB4 levels, compared with the HCO diet, increased apoptosis and diminished the mono-ubiquitylated PCNA levels, which is related to DNA damage. Tumors from rats fed the EVOO diet displayed a more benign phenotype, whereas those from rats fed the HCO diet were biologically more aggressive. In conclusion, high EVOO and corn oil diets exert their modulatory effects on breast cancer through a different combination of Ras signaling pathways, a different proliferation-apoptosis balance and probably distinct levels of DNA damage.
Introduction
Breast cancer is the most common cancer in women of Western countries (1) . Its association with dietary fat has been examined for a long time and it remains controversial (2, 3) . The main epidemiological support comes from ecological studies, while, in contrast, analytical epidemiology has generated conflicting data. Whereas a positive association between total fat intake and the risk of breast cancer seems to be well established, the relationship with specific subtypes of fat is less consistent (4) . Experimental studies have reinforced the notion of the fat-breast cancer link. In animal studies, fat-enriched diets increase mammary tumor incidence, independent of caloric intake and body weight. The dietary lipids effects not only depend on the quantity but also on the type of fat, the stage of the carcinogenesis and the mammary gland differentiation (5, 6) . In general, n-6 polyunsaturated fatty acids (PUFA), especially linoleic acid (LA; 18:2n-6), have strong tumor-enhancing effects. Saturated fatty acids are weaker stimulators, whereas n-3 PUFA, conjugated LA and c-linolenic acid have shown inhibitory effects (3, 5, 7) . Oleic acid (OA; 18:1n-9), a monounsaturated fatty acid present in high levels in olive oil, is of special interest. The Mediterranean diet, characterized by a high consumption of extra-virgin olive oil (EVOO), which is also rich in bioactive compounds such as antioxidants, is associated with a lower incidence of certain cancers, including breast cancer, as well as coronary heart disease (8, 9) . Experimentally, although there is growing evidence of a chemopreventive effect of EVOO, there are conflicting results (7, 10) .
The specific mechanisms of the dietary lipid effects on breast cancer have not been well elucidated but alterations in hormonal status, structure and function of cell membranes, cell signaling transduction pathways, oxidative stress, gene expression and the immune system have been reported (10) .
Ras proteins function as molecular switches of many signaling pathways that regulate cell growth, differentiation and survival (11) . Mutational-activated Ras as well as the upregulation of normal Ras have been shown to play a role in mammary tumorigenesis and metastasis (12) . The ErbB family of receptor tyrosine kinases is essential in triggering Ras signaling cascades, and alterations of its members are all linked to carcinogenesis (13, 14) . The most highly characterized effector pathways of activated Ras are Raf-1/extracellular signalregulated kinase (ERK) 1/2, phosphatidyl inositol 3-kinase (PI3K)/ Akt and RalGDS/RalA/B. They modulate a broad array of cellular functions including proliferation, survival, apoptosis, motility, transcription, metabolism and differentiation (15) (16) (17) . While Raf-1/ ERK1/2 and PI3K/Akt pathways are known to play a key role in breast cancer growth and apoptosis, the contribution of the Ral guanosine triphosphatases in mammary tumorigenesis is still unclear (18) .
We have previously demonstrated that high corn oil (HCO), rich in LA, and high EVOO diets differentially modulate the clinical behavior and histopathological features of rat 7,12-dimethylbenz(a)anthracene-induced mammary adenocarcinomas, according to their stimulating and protective effects, respectively (19, 20) . We have also shown that changes in tumor fatty acid composition and in the expression of cell proliferation and differentiation related genes account for these differential modulatory effects (10, 21, 22) . To gain insight into the complex mechanisms underlying these effects, in this study, the possible involvement of the ErbB/Ras pathway, as well as its three main effectors, i.e. ERK1/2, Akt and RalA/B, have been investigated. The results obtained have led us to explore the tumor mutation status of Ha-ras1 and the messenger RNA (mRNA) expression of two key enzymes of the mevalonate pathway, the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and squalene synthase (SQS). In addition, changes in cell proliferation and apoptosis, as well as in levels of 8-oxo-2#-deoxyguanosine (8-oxo-dG), were also investigated. dimethylbenz(a)anthracene (Sigma-Aldrich, St Louis, MO) and fed different semisynthetic diets, following a design of carcinogenesis promotion. Rats (n 5 20 for each group) were given a 3% corn oil diet (control low-fat diet group, LF), a high, 20% corn oil diet (high-fat corn oil diet group, HFCO) and a high EVOO diet-containing 3% corn oil and 17% EVOO-(high-fat olive oil diet group, HFOO) (19) . The fatty acid composition of the corn oil was palmitic acid (16:0), 11.2%; palmitoleic acid (16:1n-9), 0.2%; stearic acid (18:0), 2.1%; OA (18:1n-9), 28.2%; LA (18:2n-6), 57.1%; linolenic acid (18:3n-3), 0.9% and arachidic acid (20:0), 0.3%. The virgin olive oil contained palmitic acid, 7.89%; palmitoleic acid, 0.49%; stearic acid, 2.64%; OA, 79.03%; LA, 8.24%; linolenic acid, 0.6% and arachidic acid, 0.5%. At necropsy, macroscopic mammary lesions were rapidly removed and measured. A sample of each one was fixed in formalin for histopathology and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) analysis, whereas the rest was flash-frozen in liquid nitrogen and stored at À80°C for molecular analyses.
Protein extraction
Tumor tissue was homogenized in 250 mM Tris-HCl pH 7.2, 250 mM sucrose, 2 mM ethylenediaminetetraacetic acid, 1 mM ethyleneglycol-bis(aminoethylether)-tetraacetic acid, 50 lM NaF, 100 lM Na 3 VO 4 , protease inhibitor cocktail (Sigma-Aldrich), 10 mM b-mercaptoethanol, 5 mM MgCl 2 and 1% Triton X-100. Samples were then centrifuged at 13 000g for 20 min at 4°C and the supernatant saved as the total tumor extract. For p21Ras and RalA/B analysis, extracts from membrane and cytosol fractions were also obtained in 20 mM Tris-HCl pH 7.5, 2 mM ethylenediaminetetraacetic acid, 100 mM NaCl, 5 mM NaF, 100 lM Na 3 VO 4 , protease inhibitor cocktail, 0.5% b-mercaptoethanol, 5 mM MgCl 2 , 10% glycerol and 1% Triton X-100, following a protocol described elsewhere (23) . Protein concentration was measured using a Lowry protein assay.
Western blot analyses
Total or subcellular extracts were resolved by 8-15% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. Primary antibodies used were epidermal growth factor receptor (EGFR) (1:1000) and Ral B (1:5000) from Upstate Biotechnology (Lake Placid, NY); phospho-EGFR (Tyr1173, 1:200), phospho-Neu (Tyr1248, 1:200) and phospho-ErbB4 (Tyr1056, 1:1000) from Santa Cruz Biotechnology (Santa Cruz, CA); phospho-EGFR (Tyr1068, 1:2500), phospho-ErbB3 (Tyr1289, 1:1000), p44/42 mitogen-activated protein kinase (1:2500), phospho-p44/42 mitogen-activated protein kinase (Thr202/Tyr204, 1:2500), Akt (1:2500), phospho-Akt (Ser473, 1:2500), Caspase-3 (1:2000), proliferating cell nuclear antigen (PCNA) (1:5000) and Ubiquitin (1:1000) from Cell Signaling Technology (Danvers, MA); c-ErbB2 (1:267) and c-ErbB3 (1:400) from Thermo Fisher Scientific (Fremont, CA); c-ErbB4 (1:500) from Abcam (Cambridge, UK); pan-Ras (1:1000) from Calbiochem (Darmstadt, Germany) and Ral A (1:5000) from BD Biosciences (San Jose, CA). Immunoreactive proteins were visualized using the ECL TM Detection Reagents (GE Healthcare, Buckinghamshire, UK). Densitometric values of bands were normalized to the mean value of three replicates of a control tumor sample and then to the microgram of protein loaded.
Ras-guanosine triphosphate and RalA/B-guanosine triphosphate pulldown assays The capacity of Ras-guanosine triphosphate (GTP) to bind Ras-binding domain of Raf-1 was used to analyze the active p21Ras. Three-hundred micrograms of total or cytosolic extracts and 150 lg of the membrane extract were incubated for 2 h at 4°C with glutathione sepharose-4B beads (GE Healthcare) pre-coupled with glutathione S-transferase (GST)-Ras-binding domain of Raf-1. Beads were washed in the above-described buffer with (total and membrane extracts) or without Triton X-100 (cytosol extract). For RalA/B-GTP measurement, their ability to bind to the activated form of RALBP1 was used. Two-hundred and fifty micrograms of subcellular extracts were incubated with GST-RALBP1 protein bound to agarose beads (Upstate Biotechnology) for 2 h at 4°C. Proteins were boiled off the beads in Laemmli sample buffer and analyzed by western blot.
Immunoprecipitation
To identify mono-ubiquitylated PCNA (Ubi-PCNA), immunoprecipitation of total PCNA protein was performed, followed by immunodetection with the ubiquitin antibody. Briefly, 300 lg of total extract without b-mercaptoethanol were incubated overnight at 4°C with 3 ll of PCNA antibody. The resulting pellet was washed, solubilized, incubated together with the previously prepared Protein A-Agarose Fast Flow (Sigma-Aldrich) for 2 h at 4°C and analyzed by western blot.
DNA extraction and detection of c-Ha-ras1 point mutation Genomic DNA was isolated by phenol-chloroform extractions. The codon 61 c-Ha-ras1 mutation was detected by Southern blot, as described previously (24) , using a digoxigenin-labeled v-Ha-ras probe (Oncor, Gaithersburg, MD) synthesized through the PCR DIG Probe Synthesis kit (Roche Applied Science, Mannheim, Germany). It was also assessed by allele-specific mismatch amplification mutation assays according to Cha et al. (25) . The primers used were as follows: 5#-GTAGGACCCTTAAGCTGTGT-3# (forward); 5#CATGGCACTATACTCTTCCA-3# (reverse). One microgram of genomic DNA was amplified using Ready-To-Go Polymerase Chain Reaction (PCR) Beads (GE Healthcare) for 30 cycles [94°C for 1 min, 55°C for 1 min and 72°C for 1 min] followed by a final extension at 72°C for 5 min. A 120 bp fragment was detected by agarose gel electrophoresis in mutated allele-bearing samples. To confirm the presence of the mutation, a 256 bp fragment of c-Ha-ras1 second exon was amplified, using the primers 5#-GTAGGACCCTTAA-GCTGTGT-3# (forward) and 5#-CCTTCCTCACATATGCCAT-3# (reverse) and one-hundred nanogram of DNA in the reaction conditions described above. PCR products were then 2% gel purified and automatically sequenced.
RNA extraction, reverse transcription and real-time PCR mRNA expression of HMG-CoA reductase and SQS was analyzed by real-time PCR. Total RNA was isolated using the guanidinium thiocyanate method, and genomic DNA was removed by DNase treatment. RNA integrity and quantity were evaluated using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Two micrograms of total RNA were reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Twenty-five nanograms of complementary DNA were amplified by PCR with the fluorescent TaqMan methodology (Applied Biosystems) in the iCycler iQ Real-Time PCR detection system (Bio-Rad Laboratories, Hercules, CA). Reactions were prepared with the TaqMan Universal PCR Master Mix and the suitable TaqMan assay (Hmgcr: Rn00565598_m1; Sqs: Rn0057323_m1 and Hprt: Rn0152840_m1). Complementary DNA was denatured for 10 min at 95°C and amplified for 40 cycles of 15 s at 95°C and 60 s at 60°C. The gene expression was normalized to Hprt as a control transcript using DCt methodology (Ct as PCR cycle crossing the threshold).
Apoptosis detection
Apoptosis was assessed by western blot of cleaved Caspase-3. It was also detected through the TUNEL assay using the ApopTag Plus Peroxidase In Situ Detection Kit (Chemicon, Concord Road, MA) according to the manufacturer's protocol. Apoptotic cells were visualized under an Axiostar Plus microscope (Carl Zeiss MicroImaging, S.L., Barcelona, Spain).
DNA enzymatic digestion and 8-oxo-dG assay DNA enzymatic digestion and 8-oxo-dG assay were performed according to Oltra et al. (26) . The amount of 8-oxo-dG and deoxyguanosine in the DNA digest was measured by electrochemical and ultraviolet absorbance detection, respectively.
Characterization of tumor phenotype
Based on the modified Scarff-Bloom-Richardson grading scheme (20) , carcinomas were classified as well (Grade I), moderately (Grade II) or poorly (Grade III) differentiated. Mitotic activity was classified into five classes, defined on the basis of the number of mitoses in 10 high-power fields, at Â400 magnification as follows: (i) 3; (ii) 4-6; (iii) 7-9; (iv) 10-19 and (v) !20. The tumor growth was characterized through the following statistics: tumor volume at sacrifice, Vs; area below the tumor growth curve, Area; and rate of linear growth (V/tumor age), V/age.
Statistical analysis
Statistical analyses were performed using SPSS software (Version 15.0). The non-parametric Mann-Whitney's U-test was used for quantitative data and the chi-squared test for qualitative data. The non-parametric correlations were carried out through Kendall's tau-b and Spearman's rho tests. The level of significance was established at P ,0.05. Only mammary adenocarcinomas with noticeable levels of a particular protein studied were considered.
Results

Expression and activity of the ErbB receptors
Immunoblot analyses revealed no differences in the tumor expression of the membrane-bound full-length proteins ErbB1, ErbB2, ErbB3 and ErbB4 due to the dietary lipids ( Figure 1 ). Regarding ErbB4, the levels of the 80 kDa form, identified as a membranebound and/or soluble (m80/s80) cleavage product by comparison with a positive control cell line, were significantly lower in the HFOO group, as compared with the HFCO group (P 5 0.013). The levels of the active phospho-ErbB receptors (p-ErbB1 Tyr1068, p-ErbB2 Tyr1248, p-ErbB3 Tyr1289 and p-ErbB4 Tyr 1056) were not significantly changed by dietary lipids either. It is noteworthy that the ErbB1 receptor was found not to be phosphorylated on tyrosine 1173, and the only phospho-ErbB4 was that corresponding to the 80 kDa form.
p21Ras expression and activity
The p21Ras levels were significantly higher in total (P 5 0.019) and membrane (P 5 0.030) extracts from the HFOO group, as compared with the control, and also to the HFCO group (P 5 0.037 and P 5 0.032, respectively) ( Figure 2 ). No differences were observed in the p21Ras levels in the cytosolic fractions, which were lower than those of membranes. The active GTP-bound p21Ras levels were significantly diminished in the HFOO group both in total (P 5 0.046) and membrane fraction (P 5 0.014) extracts, as compared with the control, and the HFCO group (P 5 0.01 and P 5 0.012, respectively). No significant amounts of p21Ras-GTP were found in the cytosol. No changes in p21Ras and p21Ras-GTP levels were observed between the HFCO and the control.
c-Ha-ras1 mutation status To determine whether the high EVOO diet modified Ras activity by changing the mutation frequency of c-Ha-ras1, the occurrence of the 
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A/T transversion that dimethylbenz(a)anthracene induces in the Ha-ras codon 61 was investigated. The mutation frequency in the distinct experimental groups was as follows: LF 5 17% (5/29); HFCO 5 23.5% (8/34) and HFOO 5 18% (6/34), the differences not being statistically significant. The global frequency of Ha-ras mutation was 19.6% (19/97) . No correlation between the presence of Ha-ras mutation and the levels of protein activity or mRNA expression in a particular tumor sample was seen (results not shown). However, tumors harboring the Ha-ras mutation displayed ages significantly higher (P 5 0.035) than wild-type tumors, irrespective of the type of diet (median values 5 115.5 and 92 days, respectively).
HMG-CoA reductase and SQS expression
We also explored whether the changes in the p21Ras expression and activity levels found in the HFOO group were related to a specific modulation of the mevalonate pathway. The mRNA expression of HMG-CoA reductase and SQS was analyzed by real-time PCR. The median values for the former were 1.83 (LF, n 5 17), 1.66 (HFCO, n 5 12) and 1.80 (HFOO, n 5 12). The medians for SQS were 1.11 (LF, n 5 17), 1.00 (HFCO, n 5 12) and 1.23 (HFOO, n 5 12). In both cases, differences were not statistically significant.
Ras effector pathways status
The Raf-1/ERK1/2, PI3K/Akt and RalGDS/RalA/B pathways were evaluated through the analysis of the expression and activity of ERK1/ 2, Akt and RalA/B proteins, respectively. As shown in Figure 3A , the protein levels of ERK1/2 were significantly reduced in tumors from the HFCO (P 5 0.022) and HFOO groups (P 5 0.019), in comparison with the control. As for ERK1/2 activity, a non-significant increase of .2-fold in the medians of the phosphorylated proteins due to the high-fat diets was found. Whereas almost all tumors (92.9-100%) expressed phospho-ERK1, the percentage of positive phospho-ERK2 tumors was LF 5 50% (7/14), HFCO 5 84.2% (16/19) and HFOO 5 56.3% (9/16), these differences being statistically significant (P 5 0.037) for the HFCO group, when compared with the control. As regards the PI3K/Akt pathway ( Figure 3B ), a significant decrease in the Akt expression levels in the HFCO (P 5 0.01) and HFOO groups (P 5 0.03), as compared with the control, was found. In contrast, the phospho-Akt levels were reduced by $2-fold in the HFOO group, in comparison with the other groups, which displayed similar levels. The HFCO group showed the highest phospho-Akt:total Akt ratio (median values: LF 5 0.024; HFCO 5 0.08 and HFOO 5 0.026). Finally, as regards the RalGDS/RalA/B pathway ( Figure 3C and D) , neither expression nor activity levels of RalA/B proteins were different among experimental groups.
Apoptosis analysis
In view of the EVOO-induced changes in ERK1/2 and Akt activities, it was investigated whether dietary lipids may modify the apoptosis rate. The analysis of Caspase-3 through immunoblotting showed that EVOO significantly increased the levels of 17 kDa active Caspase-3, as compared with the control (P 5 0.045) and HFCO groups (P 5 0.008), which displayed similar levels ( Figure 4A ). These differences were qualitatively confirmed by TUNEL ( Figure 4B ).
Cellular proliferation
Tumor cell proliferation was firstly evaluated by measuring mitotic activity in hematoxylin and eosin-stained paraffin-embedded tumor sections. Adenocarcinomas from the HFCO group displayed a higher mitotic index than the other groups (P 5 0.013 versus the LF group) ( Figure 5A and Table I ). Cell proliferation was also assessed by western blot of the PCNA marker. A 36 kDa species corresponding to the unmodified PCNA and two other higher molecular weight species were detected. The slowly migrating form corresponded to the 46 kDa Ubi-PCNA, as was verified by immunoprecipitation. The PCNA levels were not different among groups ( Figure 5B ). In contrast, the Ubi-PCNA levels were significantly lower in the HFOO group than in the control (P 5 0.033) and the HFCO groups (P 5 0.017). In the HFCO group the Ubi-PCNA levels were higher than in the control, although not significantly so ( Figure 5B ). When the total PCNA levels were estimated for each sample by adding PCNA and Ubi-PCNA values, they were also significantly lower in the HFOO group than in the control (P 5 0.033) and the HFCO groups (P 5 0.047).
8-oxo-dG assay
In view of the changes in the Ubi-PCNA levels, we asked ourselves whether mammary adenocarcinomas displayed different DNA damage levels due to dietary lipids. The levels of the pre-mutagenic 8-oxo-dG base were measured in the genomic DNA isolated from tumors of the distinct dietary groups. The median values obtained were as follows (8-oxo-dG/10 6 dG): LF 5 3.03 (n 5 21); HFCO 5 2.22 (n 5 25) and HFOO 5 2.97 (n 5 25). The differences were not statistically significant.
Tumor phenotype
Here, it was verified that the group of tumors analyzed in this work for each dietary treatment displayed a different phenotype (Table I) . Thus, adenocarcinomas from the HFCO group showed a higher morphological malignancy, based on the greater degree of the Scarff-BloomRichardson scheme and the higher mitotic activity (P 5 0.033 and P 5 0.013, respectively, versus the control group), and a more aggressive growth as indicated by the higher values of the tumor volume parameters (Vs, P 5 0.05; Area, P 5 0.029 and V/age, P 5 0.018; versus the HFOO group). In contrast, adenocarcinomas from the HFOO group showed morphological and clinical features consistent with a lower degree of malignancy, similar to control tumors.
Discussion
The present study shows that the EVOO diet, which negatively modulates the experimental mammary carcinogenesis, decreases Ã P , 0.05, non-parametric Mann-Whitney's U-test.
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Ras activity, without the involvement of ErbB receptors, and generates a particular cell signaling scenario resulting in a proliferationapoptosis balance tilted in favor of apoptosis. In contrast, the HCO diet stimulates mammary cancer through a combination of Ras-independent cell signaling pathways, which deflects this balance in favor of the survival of transformed mammary cells. Moreover, the Tumor histological sections from each group were subjected to TUNEL assay to detect apoptotic nuclei (brown) and counterstained with 0.5% methyl green to detect intact nuclei (green). Apoptotic cells were identified as cells with nuclear brown staining and morphological characteristics of apoptosis such as nuclear condensation, a perinuclear halo and apoptotic bodies. Slides from rat mammary gland in regression after weaning were used as positive controls, whereas DNase I-treated sections without terminal deoxynucleotidyl transferase enzyme were performed as negative controls. Low-power pictures at Â200 original magnification, high-power pictures (insets) at Â400 (LF and HFCO groups) or Â600 (HFOO) original magnification. EVOO diet was indirectly associated with lower levels of tumor DNA damage. All of these data confirm and significantly extend our previous works showing the more benign tumor phenotype of mammary cancer under the influence of EVOO. Our initial expectation was that the modulatory effects of dietary lipids on mammary cancer would involve changes in ErbB signaling since this receptor family plays important roles in mammary development and human breast cancer (14, 27) . However, the expression and activity of ErbB1, ErbB2 and ErbB3 were not altered due to the diet, suggesting that these receptors are not required for the lipid effects on mammary carcinogenesis. We previously reported that the HCO diet increased mRNA levels of the ErbB1/EGFR truncated receptor, which seems to interfere in the appropriate ErbB signaling (28) . Unfortunately, it was not possible to confirm this possibility because of the lack of suitable antibodies. No effect on EGFR expression and ErbB2 suppression due to the OA or phenols have been reported in ErbB2-overexpressing breast cancer cells (29) . We found no changes either in the expression of the full-length ErbB4, but levels of the 80 kDa band significantly decreased in the HFOO group, as compared with the HFCO group. This band may correspond both to the transmembrane peptide (m80) and the soluble intracellular domain (s80), also called 4ICD. 4ICD may be generated sequentially by the ligand-binding and kinase activity-dependent proteolytic processing of ErbB4 and appears to mediate most of ErbB4 activities in the breast, although its biological significance in breast cancer is poorly known (30) . Since the mammary gland exclusively expresses a cleavable ErbB4 isoform (31), the m80/s80 band detectable in ErbB4 and phospho-ErbB4 immunoblots would correspond to the activated receptor, but differences were only statistically significant in the first case. Further investigation will be necessary to establish the potential role of ErbB4 in EVOO effects.
The possible involvement of p21Ras in the dietary fat-breast cancer link was next investigated. The EVOO diet significantly decreased p21Ras activity, but it significantly increased protein levels. In contrast, no changes were observed in p21Ras due to the HCO diet. These findings suggest that p21Ras has a role in the negative modulatory effect of EVOO on breast cancer, whereas it is not involved in the stimulatory effect of the corn oil. As far as we know, this is the first report to show that EVOO influences in the p21Ras status in cancer. In particular, our data indicated that EVOO interferes somehow in its activation, resulting in an increase of the relative levels of the nonactivated protein. The possible mechanisms by which EVOO underregulates p21Ras activity could include either (i) decreasing the ras mutation rate or (ii) modifying the regulation of the mevalonate pathway, which is the source of the prenyl groups needed for the posttranslational modification of p21Ras and its subsequent activation (32) . The first possibility can be ruled out because the frequency of the activating c-Ha-ras1 mutation was not changed due to the diet. Interestingly, the median age of the mutation-bearing tumors was higher than that of the wild-type tumors, irrespective of the diet, which would be consistent with a selective advantage of growth conferred by ras mutation to the mammary tumors (33) . To our knowledge, there are no published data about the influence of olive oil on tumor ras mutation. A decreased percentage of tumors harboring ras mutations due to HCO diets has been described in other mammary cancer models (34) . To address the second possibility, we analyzed the mRNA expression of HMG-CoA reductase and SQS. Results discarded this possibility, at least at the enzyme expression level. They did not support the idea either that the chemopreventive effect of squalene on cancer, a minor compound of EVOO, is due to the HMG-CoA reductase inhibition (35) . It is probably that squalene should be at very high doses (1%) to exert this effect. We cannot rule out, however, that EVOO may modulate the enzyme activity or other critical steps of the p21Ras processing.
Long-chain n-3 PUFA has also been described to decrease Ras levels and/or activity in rat colon (23, 36) . It has been proposed that this may be the result of changes in membrane lipid composition, specifically the lipid raft and caveolae, thus altering the membrane structure and function and, in this way, influencing the intracellular trafficking and subcellular location of lipidated proteins such as p21Ras (37) . The effects observed in p21Ras due to the EVOO diet could also be a consequence of an OA enrichment of cell membranes. Future studies will address this possibility.
When Ras effector pathways were examined, increased ERK1/2 activity and reduced ERK1/2 expression were found owing to the high-fat diets, the differences in the expression being statistically significant. These results suggest an unspecific effect of these diets upregulating this proliferating pathway, which would not be elicited by ErbB receptors and would be mediated, at least partly, by a p21Ras-independent mechanism. The reduced ERK1/2 expression concomitant to the increased activity reminds one of a cellular feedback mechanism. The different activation state of ERK1 and ERK2 obtained herein, in agreement with that found by other authors, suggests isoform-specific roles (38) (39) (40) .
The EVOO diet also decreased both Akt expression and activation, whereas the HCO diet only decreased its expression. Given that Akt contributes significantly to survival and proliferation in cancer, and reduced phospho-Akt levels have been associated with apoptosis induction (41), our results suggest that EVOO effects may be linked to a downregulation of the pro-survival p21Ras/Akt pathway. In Dietary lipids and breast cancer contrast, tumors from the HFCO group displayed the highest phospho-Akt:total Akt ratio, consistent with the stimulating effect of this diet on tumor growth. Currently, we have no explanation for the decreased Akt expression in both high-fat diet groups. In fact, its transcriptional regulation remains largely unknown. In human breast cancer cells, OA both increased (42) and decreased (29) active Akt, and in colon cancer, hydroxytyrosol, an antioxidant from EVOO, abolished Akt phosphorylation and induced a transient ERK1/2 phosphorylation-dephosphorylation (43) .
We also investigated the RalGDS-RalA/B pathway. Ral proteins regulate vesicle trafficking, actin cytoskeletal dynamics and transcription in response to mitogenic cascades (15) . They seem to have a pivotal contribution to the regulatory framework supporting tumorigenesis (18) . Dietary lipids did not modify the expression or activity of RalA/B proteins, suggesting a Ral-independent modulation of mammary carcinogenesis as well as a specificity of Ras signaling in the case of the EVOO diet.
The Akt downregulation due to the EVOO diet may seem contradictory to its upregulatory effect on ERK1/2 activity since the latter mainly provides cell survival and proliferation signals. However, a pro-apoptotic role of ERK1/2 depending on the kinetics and duration of its activation has been suggested (43) . Thus, under the influence of the EVOO diet, the relative balance between ERK1/2 and Akt pathways would result in a pro-apoptotic cellular scenario. Interestingly, a variety of anticancer drugs that stimulate apoptosis have been reported to downregulate the Akt pathway and upregulate the ERK one (44, 45) . Consistent with this hypothesis, the activated Caspase-3 levels increased in the HFOO group. Caspase-3 is considered the main executioner of the caspase cascade involved in both extrinsic and intrinsic apoptosis (46) . TUNEL staining of mammary tumor sections confirmed increased apoptosis due to the EVOO diet. At present, there is growing evidence of apoptosis modulation by conjugated LA (47), long-chain n-3 PUFA (48) and OA and olive oil (42, 49, 50) .
Our results also showed that the high EVOO diet did not exert any significant effect on tumor cell proliferation, as the mitotic index and PCNA levels indicated. Thus, a proliferation-apoptosis balance tilted toward apoptosis might contribute to the ability of this diet to negatively regulate tumor growth. On the other hand, the HCO diet significantly increased tumor mitotic activity. The fact that the PCNA levels did not reflect this effect may be due to the loss of the simple relation between PCNA expression and cell proliferation that has been described in some cancers (51) . The higher proliferation rate associated with the HCO diet is consistent with our results supporting its role in transducing survival/proliferation signals and, therefore, with its stimulatory effect on cancer.
Interestingly, Ubi-PCNA levels were significantly decreased in the HFOO group and non-significantly increased in the HFCO group. PCNA ubiquitylation specifically occurs when DNA is damaged or replication forks stalled. PCNA mono-ubiquitylation mediates translesion synthesis and poly-ubiquitylation promotes error-free DNA damage tolerance pathways (52) . Our data suggest less DNA damage owing to the EVOO diet and higher genotoxic stress due to the corn oil diet. Nevertheless, no significant changes were observed for the pre-mutagenic 8-oxo-dG base, which is one of the most common biomarkers of oxidative DNA damage (53) . It is probably that the 8-oxo-dG levels did not reflect the total DNA adduct levels and that dietary lipids may have an effect on other DNA lesions. High levels of malondialdehyde-derived and etheno-DNA adducts have been described due to n-6 PUFA (54), whereas sunflower and olive oils did not increase levels of hepatic 1,N 2 -propanodeoxyguanosine and 8-oxo-dG (55) . The effect of EVOO on the oxidative DNA damage and the relationship with its pro-apoptotic effect must be further investigated.
In summary, even though caution must be exercised when applying experimental data to human breast cancer, our findings emphasize the importance that certain dietetic habits may have on cancer promotion. Through a different modulation of cell signaling pathways, which modifies the cell proliferation-apoptosis balance, and probably a different level of DNA damage, the high EVOO and corn oil diets exert differential effects on this cancer. These results would help in the design of future strategies of secondary, and even primary, prevention of breast cancer. The sponsors had no role in the study design, data collection and analysis, interpretation of results, the preparation of the manuscript, the decision to submit the manuscript for publication and the writing of the manuscript.
